Brickell Biotech Inc (NASDAQ:BBI)

3.04
Delayed Data
As of 4:00pm ET
 -0.04 / -1.30%
Today’s Change
1.05
Today|||52-Week Range
8.96
+102.67%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$23.6M

Company Description

Brickell Biotech, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in 2009 and is headquartered in Boulder, CO.

Contact Information

Brickell Biotech, Inc.
5777 Central Avenue
Boulder Colorado 80301
P:(720) 505-4755
Investor Relations:

Employees

Shareholders

Individual stakeholders20.61%
Other institutional11.43%
Mutual fund holders1.11%

Top Executives

There are no executives to display.